 Fan Zhang
Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Single-Cell Analysis | 13 | 2025 | 313 | 3.030 |
Why?
| | Arthritis, Rheumatoid | 17 | 2025 | 1167 | 2.920 |
Why?
| | Synovial Membrane | 9 | 2024 | 117 | 1.700 |
Why?
| | Computational Biology | 7 | 2025 | 644 | 1.640 |
Why?
| | Transcriptome | 7 | 2025 | 971 | 1.560 |
Why?
| | Gene Expression Profiling | 4 | 2025 | 1774 | 1.380 |
Why?
| | B-Lymphocytes | 6 | 2025 | 847 | 1.220 |
Why?
| | Machine Learning | 3 | 2025 | 493 | 0.960 |
Why?
| | Algorithms | 7 | 2025 | 1704 | 0.910 |
Why?
| | Th17 Cells | 2 | 2025 | 108 | 0.910 |
Why?
| | Immunophenotyping | 2 | 2025 | 318 | 0.880 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2020 | 539 | 0.740 |
Why?
| | Lymphocyte Activation | 2 | 2025 | 1142 | 0.730 |
Why?
| | CD4-Positive T-Lymphocytes | 5 | 2025 | 1091 | 0.720 |
Why?
| | CD8-Positive T-Lymphocytes | 5 | 2025 | 900 | 0.720 |
Why?
| | Cytokines | 5 | 2023 | 2085 | 0.660 |
Why?
| | Fibroblasts | 8 | 2025 | 996 | 0.650 |
Why?
| | Macrophages | 3 | 2023 | 1547 | 0.610 |
Why?
| | Genome-Wide Association Study | 2 | 2024 | 1431 | 0.590 |
Why?
| | Sequence Analysis, DNA | 2 | 2017 | 812 | 0.510 |
Why?
| | Inflammation | 8 | 2025 | 2837 | 0.480 |
Why?
| | Sequence Analysis, RNA | 3 | 2024 | 452 | 0.460 |
Why?
| | Anti-Citrullinated Protein Antibodies | 2 | 2025 | 115 | 0.410 |
Why?
| | Colitis, Ulcerative | 3 | 2024 | 136 | 0.410 |
Why?
| | Models, Theoretical | 1 | 2017 | 578 | 0.400 |
Why?
| | Phenotype | 4 | 2025 | 3196 | 0.370 |
Why?
| | Software | 3 | 2025 | 665 | 0.360 |
Why?
| | Humans | 31 | 2025 | 137585 | 0.300 |
Why?
| | Neoplasms | 2 | 2021 | 2671 | 0.300 |
Why?
| | Granzymes | 2 | 2025 | 50 | 0.270 |
Why?
| | Gene Expression | 3 | 2024 | 1502 | 0.260 |
Why?
| | Lung Diseases, Interstitial | 2 | 2024 | 638 | 0.250 |
Why?
| | Cluster Analysis | 2 | 2025 | 499 | 0.250 |
Why?
| | T-Lymphocytes | 2 | 2025 | 1996 | 0.250 |
Why?
| | Genetic Predisposition to Disease | 2 | 2024 | 2426 | 0.240 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2024 | 2189 | 0.230 |
Why?
| | Adalimumab | 1 | 2024 | 48 | 0.220 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2024 | 38 | 0.220 |
Why?
| | Receptors, Glucocorticoid | 1 | 2024 | 155 | 0.200 |
Why?
| | Adipocytes | 1 | 2024 | 222 | 0.200 |
Why?
| | Microglia | 1 | 2025 | 251 | 0.200 |
Why?
| | Hydrocortisone | 1 | 2024 | 322 | 0.190 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2025 | 248 | 0.190 |
Why?
| | Complement System Proteins | 1 | 2025 | 327 | 0.180 |
Why?
| | Complement Activation | 1 | 2025 | 415 | 0.180 |
Why?
| | Crohn Disease | 2 | 2024 | 243 | 0.180 |
Why?
| | Quantitative Trait Loci | 1 | 2023 | 380 | 0.180 |
Why?
| | Receptors, IgG | 1 | 2021 | 75 | 0.180 |
Why?
| | Flow Cytometry | 3 | 2020 | 1178 | 0.180 |
Why?
| | Antirheumatic Agents | 1 | 2024 | 293 | 0.180 |
Why?
| | Immunity, Innate | 2 | 2024 | 828 | 0.170 |
Why?
| | Biomarkers, Tumor | 2 | 2020 | 1276 | 0.170 |
Why?
| | Leukocytes | 2 | 2019 | 311 | 0.170 |
Why?
| | Signal Transduction | 3 | 2024 | 5079 | 0.170 |
Why?
| | Osteoarthritis, Knee | 1 | 2023 | 254 | 0.170 |
Why?
| | Chromatin | 1 | 2024 | 519 | 0.160 |
Why?
| | Glucocorticoids | 1 | 2024 | 594 | 0.160 |
Why?
| | Transcription Factors | 2 | 2025 | 1719 | 0.160 |
Why?
| | Organ Specificity | 1 | 2020 | 305 | 0.160 |
Why?
| | Neoplasm Grading | 1 | 2020 | 307 | 0.160 |
Why?
| | Heparin-binding EGF-like Growth Factor | 1 | 2019 | 16 | 0.160 |
Why?
| | Genome | 1 | 2021 | 300 | 0.150 |
Why?
| | Lupus Nephritis | 1 | 2019 | 63 | 0.150 |
Why?
| | Antigens, Neoplasm | 1 | 2021 | 319 | 0.150 |
Why?
| | Cell Communication | 1 | 2020 | 315 | 0.150 |
Why?
| | Colon | 1 | 2021 | 282 | 0.150 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2021 | 242 | 0.150 |
Why?
| | Gene Frequency | 2 | 2017 | 521 | 0.150 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2021 | 652 | 0.140 |
Why?
| | Workflow | 1 | 2019 | 165 | 0.140 |
Why?
| | Disease Progression | 1 | 2025 | 2757 | 0.140 |
Why?
| | Bayes Theorem | 2 | 2017 | 405 | 0.140 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2019 | 367 | 0.140 |
Why?
| | Cell Differentiation | 1 | 2025 | 1991 | 0.140 |
Why?
| | Genomics | 2 | 2020 | 795 | 0.140 |
Why?
| | Case-Control Studies | 1 | 2025 | 3556 | 0.130 |
Why?
| | Gene Expression Regulation | 2 | 2023 | 2607 | 0.130 |
Why?
| | T-Lymphocyte Subsets | 1 | 2019 | 417 | 0.130 |
Why?
| | Monte Carlo Method | 1 | 2017 | 148 | 0.130 |
Why?
| | Markov Chains | 1 | 2017 | 126 | 0.130 |
Why?
| | Tumor Microenvironment | 1 | 2020 | 674 | 0.130 |
Why?
| | Monocytes | 1 | 2019 | 563 | 0.120 |
Why?
| | Neutrophils | 1 | 2021 | 1238 | 0.120 |
Why?
| | Mice | 7 | 2025 | 17787 | 0.110 |
Why?
| | Animals | 10 | 2025 | 36940 | 0.100 |
Why?
| | Male | 9 | 2025 | 67762 | 0.100 |
Why?
| | Autoimmunity | 1 | 2019 | 908 | 0.100 |
Why?
| | Plasma Cells | 2 | 2024 | 71 | 0.100 |
Why?
| | Middle Aged | 5 | 2025 | 33479 | 0.100 |
Why?
| | Adult | 6 | 2025 | 37929 | 0.100 |
Why?
| | Female | 9 | 2025 | 73304 | 0.090 |
Why?
| | Lung | 2 | 2024 | 4060 | 0.090 |
Why?
| | Kidney | 1 | 2019 | 1468 | 0.090 |
Why?
| | Complement Fixation Tests | 1 | 2001 | 6 | 0.090 |
Why?
| | Plants, Medicinal | 1 | 2001 | 22 | 0.090 |
Why?
| | Biomarkers | 2 | 2019 | 4149 | 0.090 |
Why?
| | Interferons | 2 | 2024 | 202 | 0.080 |
Why?
| | Polysaccharides | 1 | 2001 | 79 | 0.080 |
Why?
| | Epigenesis, Genetic | 2 | 2025 | 660 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2024 | 1242 | 0.080 |
Why?
| | Aged | 2 | 2025 | 23961 | 0.070 |
Why?
| | Immunotherapy | 2 | 2024 | 641 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5472 | 0.070 |
Why?
| | Cells, Cultured | 2 | 2025 | 4193 | 0.070 |
Why?
| | Mice, Knockout | 2 | 2024 | 3015 | 0.060 |
Why?
| | Complement C3-C5 Convertases | 1 | 2025 | 24 | 0.060 |
Why?
| | Interferon Regulatory Factors | 1 | 2025 | 39 | 0.060 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2024 | 9 | 0.060 |
Why?
| | Complement C4 | 1 | 2025 | 28 | 0.060 |
Why?
| | Complement C3b | 1 | 2025 | 34 | 0.060 |
Why?
| | Complement C5a | 1 | 2025 | 71 | 0.060 |
Why?
| | Complement Membrane Attack Complex | 1 | 2025 | 39 | 0.060 |
Why?
| | Adipogenesis | 1 | 2024 | 55 | 0.060 |
Why?
| | Oncostatin M | 1 | 2023 | 6 | 0.050 |
Why?
| | Lymphocyte Subsets | 1 | 2024 | 87 | 0.050 |
Why?
| | Transcription Factor AP-1 | 1 | 2024 | 92 | 0.050 |
Why?
| | Arthritis | 1 | 2024 | 95 | 0.050 |
Why?
| | Mutation | 1 | 2015 | 3958 | 0.050 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2024 | 165 | 0.050 |
Why?
| | Mucous Membrane | 1 | 2024 | 125 | 0.050 |
Why?
| | T-Box Domain Proteins | 1 | 2024 | 98 | 0.050 |
Why?
| | High-Throughput Screening Assays | 1 | 2025 | 158 | 0.050 |
Why?
| | Adaptive Immunity | 1 | 2024 | 165 | 0.050 |
Why?
| | Gene Regulatory Networks | 1 | 2025 | 305 | 0.050 |
Why?
| | Rheumatoid Factor | 1 | 2024 | 175 | 0.050 |
Why?
| | Methotrexate | 1 | 2024 | 260 | 0.050 |
Why?
| | Mice, Inbred C57BL | 2 | 2024 | 5757 | 0.050 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2021 | 45 | 0.040 |
Why?
| | Antigen-Antibody Complex | 1 | 2021 | 90 | 0.040 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2021 | 99 | 0.040 |
Why?
| | Symptom Flare Up | 1 | 2020 | 39 | 0.040 |
Why?
| | Pulmonary Fibrosis | 1 | 2024 | 402 | 0.040 |
Why?
| | Synovial Fluid | 1 | 2020 | 68 | 0.040 |
Why?
| | Endocytosis | 1 | 2021 | 172 | 0.040 |
Why?
| | Computer Simulation | 1 | 2025 | 978 | 0.040 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2022 | 220 | 0.040 |
Why?
| | Patient Acuity | 1 | 2020 | 47 | 0.040 |
Why?
| | Antigen Presentation | 1 | 2021 | 218 | 0.040 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2024 | 351 | 0.040 |
Why?
| | Bone Marrow | 1 | 2021 | 286 | 0.040 |
Why?
| | Jurkat Cells | 1 | 2019 | 134 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2019 | 121 | 0.040 |
Why?
| | Cell Shape | 1 | 2019 | 57 | 0.040 |
Why?
| | Molecular Sequence Annotation | 1 | 2019 | 99 | 0.040 |
Why?
| | Lymph Nodes | 1 | 2021 | 491 | 0.040 |
Why?
| | Pain | 1 | 2024 | 756 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 622 | 0.040 |
Why?
| | Joints | 1 | 2019 | 105 | 0.040 |
Why?
| | Cell Polarity | 1 | 2019 | 141 | 0.040 |
Why?
| | Myeloid Cells | 1 | 2019 | 148 | 0.040 |
Why?
| | Dendritic Cells | 1 | 2021 | 483 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2024 | 1457 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2844 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2019 | 730 | 0.030 |
Why?
| | Lymphocytes | 1 | 2019 | 397 | 0.030 |
Why?
| | Cell Movement | 1 | 2021 | 967 | 0.030 |
Why?
| | Autoantibodies | 1 | 2024 | 1496 | 0.030 |
Why?
| | Base Sequence | 1 | 2019 | 2181 | 0.030 |
Why?
| | Biopsy | 1 | 2019 | 1129 | 0.030 |
Why?
| | Loss of Heterozygosity | 1 | 2015 | 51 | 0.030 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2015 | 83 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2015 | 343 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2021 | 2475 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2019 | 1096 | 0.020 |
Why?
| | Alleles | 1 | 2015 | 891 | 0.020 |
Why?
| | Mali | 1 | 2001 | 3 | 0.020 |
Why?
| | Chromatography, DEAE-Cellulose | 1 | 2001 | 13 | 0.020 |
Why?
| | Risk Factors | 1 | 2025 | 10388 | 0.020 |
Why?
| | Monosaccharides | 1 | 2001 | 12 | 0.020 |
Why?
| | Indicators and Reagents | 1 | 2001 | 106 | 0.020 |
Why?
| | Plant Roots | 1 | 2001 | 45 | 0.020 |
Why?
| | Carbohydrates | 1 | 2001 | 65 | 0.020 |
Why?
| | Hydrolysis | 1 | 2001 | 177 | 0.020 |
Why?
| | Molecular Weight | 1 | 2001 | 335 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2001 | 1092 | 0.020 |
Why?
| | Sheep | 1 | 2001 | 856 | 0.020 |
Why?
| | Wound Healing | 1 | 2001 | 331 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 5778 | 0.020 |
Why?
| | Amino Acids | 1 | 2001 | 497 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 2015 | 2253 | 0.010 |
Why?
|
|
Zhang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|